000 01828 a2200505 4500
005 20250517154357.0
264 0 _c20180822
008 201808s 0 0 eng d
022 _a1523-1747
024 7 _a10.1016/j.jid.2016.12.029
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWalker, Joanna L
245 0 0 _a5-Fluorouracil for Actinic Keratosis Treatment and Chemoprevention: A Randomized Controlled Trial.
_h[electronic resource]
260 _bThe Journal of investigative dermatology
_c06 2017
300 _a1367-1370 p.
_bdigital
500 _aPublication Type: Letter; Multicenter Study; Research Support, U.S. Gov't, Non-P.H.S.
650 0 4 _aAdministration, Cutaneous
650 0 4 _aAntimetabolites, Antineoplastic
_xadministration & dosage
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDouble-Blind Method
650 0 4 _aDrug Administration Schedule
650 0 4 _aFacial Dermatoses
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aFluorouracil
_xadministration & dosage
650 0 4 _aFollow-Up Studies
650 0 4 _aHumans
650 0 4 _aKeratosis, Actinic
_xdrug therapy
650 0 4 _aMale
650 0 4 _aPrecancerous Conditions
_xdrug therapy
650 0 4 _aQuality of Life
650 0 4 _aSeverity of Illness Index
650 0 4 _aTreatment Outcome
700 1 _aSiegel, Julia A
700 1 _aSachar, Moniyka
700 1 _aPomerantz, Hyemin
700 1 _aChen, Suephy C
700 1 _aSwetter, Susan M
700 1 _aDellavalle, Robert P
700 1 _aStricklin, George P
700 1 _aQureshi, Abrar A
700 1 _aDiGiovanna, John J
700 1 _aWeinstock, Martin A
773 0 _tThe Journal of investigative dermatology
_gvol. 137
_gno. 6
_gp. 1367-1370
856 4 0 _uhttps://doi.org/10.1016/j.jid.2016.12.029
_zAvailable from publisher's website
999 _c27199007
_d27199007